{"Recent": [0], "advances": [1], "in": [2, 44, 134], "next-generation": [3], "sequencing": [4, 131], "(NGS)": [5], "technologies": [6], "have": [7], "triggered": [8], "the": [9, 37, 63, 88], "rapid": [10], "accumulation": [11], "of": [12, 19, 40, 66, 87, 90, 109], "publicly": [13], "available": [14], "multi-omics": [15, 53, 102, 163], "datasets.": [16], "The": [17], "application": [18], "integrated": [20], "omics": [21], "to": [22, 36, 58, 165, 170], "explore": [23], "robust": [24], "signatures": [25, 111, 126], "for": [26, 50, 77, 150, 161], "clinical": [27, 38, 116], "translation": [28], "is": [29, 34, 157], "increasingly": [30], "emphasized,": [31], "and": [32, 68, 97, 112, 125, 146, 153, 169, 174], "this": [33], "attributed": [35], "success": [39], "immune": [41], "checkpoint": [42], "blockades": [43], "diverse": [45], "malignancies.": [46], "However,": [47], "effective": [48, 78], "tools": [49, 149], "comprehensively": [51], "interpreting": [52], "data": [54, 133, 164], "are": [55], "still": [56], "warranted": [57], "provide": [59], "increased": [60], "granularity": [61], "into": [62], "intrinsic": [64], "mechanism": [65], "oncogenesis": [67], "immunotherapeutic": [69], "sensitivity.": [70], "Therefore,": [71], "we": [72], "developed": [73], "a": [74, 84, 158], "computational": [75], "tool": [76, 160], "Immuno-Oncology": [79], "Biological": [80], "Research": [81], "(IOBR),": [82], "providing": [83], "comprehensive": [85], "investigation": [86], "estimation": [89], "reported": [91], "or": [92], "user-built": [93], "signatures,": [94], "TME": [95], "deconvolution,": [96], "signature": [98, 147], "construction": [99, 148], "based": [100], "on": [101], "data.": [103], "Notably,": [104], "IOBR": [105, 139, 156], "offers": [106], "batch": [107], "analyses": [108], "these": [110], "their": [113], "correlations": [114], "with": [115], "phenotypes,": [117], "long": [118], "non-coding": [119], "RNA": [120, 130], "(lncRNA)": [121], "profiling,": [122], "genomic": [123], "characteristics,": [124], "generated": [127], "from": [128], "single-cell": [129], "(scRNA-seq)": [132], "different": [135], "cancer": [136], "settings.": [137], "Additionally,": [138], "integrates": [140], "multiple": [141], "existing": [142], "microenvironmental": [143], "deconvolution": [144], "methodologies": [145], "convenient": [151], "comparison": [152], "selection.": [154], "Collectively,": [155], "user-friendly": [159], "leveraging": [162], "facilitate": [166], "immuno-oncology": [167], "exploration": [168], "unveil": [171], "tumor-immune": [172], "interactions": [173], "accelerating": [175], "precision": [176], "immunotherapy.": [177]}